Cite
Definitive Chemoradiation for Gastroesophageal Junction (GEJ) Adenocarcinomas: A Single-Institution Experience.
MLA
Farhan, Farshid, et al. “Definitive Chemoradiation for Gastroesophageal Junction (GEJ) Adenocarcinomas: A Single-Institution Experience.” Basic & Clinical Cancer Research, vol. 15, no. 2, Apr. 2023, pp. 1–11. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=asx&AN=177269687&authtype=sso&custid=ns315887.
APA
Farhan, F., Lashkari, M., Babaei, M., seriesht, S. M., Farazmand, B., Esmati, E., & Ghalehtaki, R. (2023). Definitive Chemoradiation for Gastroesophageal Junction (GEJ) Adenocarcinomas: A Single-Institution Experience. Basic & Clinical Cancer Research, 15(2), 1–11.
Chicago
Farhan, Farshid, Marzieh Lashkari, Mohammad Babaei, Shiva Mahdavi seriesht, Borna Farazmand, Ebrahim Esmati, and Reza Ghalehtaki. 2023. “Definitive Chemoradiation for Gastroesophageal Junction (GEJ) Adenocarcinomas: A Single-Institution Experience.” Basic & Clinical Cancer Research 15 (2): 1–11. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=asx&AN=177269687&authtype=sso&custid=ns315887.